BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37182330)

  • 1. Discovery of 6-aryl-2-(3,4,5-trimethoxyphenyl)thiazole[3,2-b][1,2,4]triazoles as potent tubulin polymerization inhibitors.
    Li N; Guan Q; Hong Y; Zhang B; Li M; Li X; Li B; Wu L; Zhang W
    Eur J Med Chem; 2023 Aug; 256():115402. PubMed ID: 37182330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based approaches for the design of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d][1,2,3]triazoles as tubulin polymerization inhibitors.
    Huang M; Han H; Liu H; Liu R; Li J; Li M; Guan Q; Zhang W; Wang D
    Eur J Med Chem; 2024 Apr; 269():116309. PubMed ID: 38471357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation, and structure-activity relationships of new tubulin polymerization inhibitors based on 5-amino-1,2,4-triazole scaffold.
    Yang F; Chen L; Lai JM; Jian XE; Lv DX; Yuan LL; Liu YX; Liang FT; Zheng XL; Li XL; Wei LY; You WW; Zhao PL
    Bioorg Med Chem Lett; 2021 Apr; 38():127880. PubMed ID: 33636303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diversity of trimethoxyphenyl-1,2,3-triazole hybrids as novel colchicine site tubulin polymerization inhibitors.
    Fu DJ; Li P; Wu BW; Cui XX; Zhao CB; Zhang SY
    Eur J Med Chem; 2019 Mar; 165():309-322. PubMed ID: 30690300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site.
    Eissa IH; Dahab MA; Ibrahim MK; Alsaif NA; Alanazi AZ; Eissa SI; Mehany ABM; Beauchemin AM
    Bioorg Chem; 2021 Jul; 112():104965. PubMed ID: 34020238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors.
    Liu R; Huang M; Zhang S; Li L; Li M; Sun J; Wu L; Guan Q; Zhang W
    Eur J Med Chem; 2021 Dec; 226():113826. PubMed ID: 34571171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and evaluation of antiproliferative and antitubulin activities of 5-methyl-4-aryl-3-(4-arylpiperazine-1-carbonyl)-4H-1,2,4-triazoles.
    Wang C; Li Y; Liu T; Wang Z; Zhang Y; Bao K; Wu Y; Guan Q; Zuo D; Zhang W
    Bioorg Chem; 2020 Nov; 104():103909. PubMed ID: 33142419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and bio-evaluation of novel 2-aryl-4-(3,4,5-trimethoxy-benzoyl)-5-substituted-1,2,3-triazoles as the tubulin polymerization inhibitors.
    Huang L; Liu M; Man S; Ma D; Feng D; Sun Z; Guan Q; Zuo D; Wu Y; Zhang W; Bao K
    Eur J Med Chem; 2020 Jan; 186():111846. PubMed ID: 31740055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors.
    Zhang J; Tan L; Wu C; Li Y; Chen H; Liu Y; Wang Y
    Eur J Med Chem; 2023 Feb; 248():115085. PubMed ID: 36621138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
    Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
    Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of flexible and rigid analogs of 4H-1,2,4-triazoles bearing 3,4,5-trimethoxyphenyl moiety as new antiproliferative agents.
    Ansari M; Shokrzadeh M; Karima S; Rajaei S; Hashemi SM; Mirzaei H; Fallah M; Emami S
    Bioorg Chem; 2019 Dec; 93():103300. PubMed ID: 31586708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of (2-(phenylamino)thieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone analogues as potent anti-tubulin polymerization agents.
    Tian C; Chen X; Zhang Z; Wang X; Liu J
    Eur J Med Chem; 2019 Dec; 183():111679. PubMed ID: 31541870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
    Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP
    Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway.
    Song J; Wang SH; Song CH; Zhang WX; Zhu JX; Tian XY; Fu XJ; Xu Y; Jin CY; Zhang SY
    Eur J Med Chem; 2022 Oct; 240():114583. PubMed ID: 35834904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of structurally diverse 6-aryl-3-aroyl-indole analogues as inhibitors of tubulin polymerization.
    Ren W; Deng Y; Ward JD; Vairin R; Bai R; Wanniarachchi HI; Hamal KB; Tankoano PE; Tamminga CS; Bueno LMA; Hamel E; Mason RP; Trawick ML; Pinney KG
    Eur J Med Chem; 2024 Jan; 263():115794. PubMed ID: 37984295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of novel thiazole-naphthalene derivatives as potential anticancer agents and tubulin polymerisation inhibitors.
    Wang G; Liu W; Fan M; He M; Li Y; Peng Z
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1694-1702. PubMed ID: 34309466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel indole-1,2,4-triazole derivatives as tubulin polymerization inhibitors.
    Wu MK; Man RJ; Liao YJ; Zhu HL; Zhou ZG
    Drug Dev Res; 2021 Nov; 82(7):1008-1020. PubMed ID: 33675542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel 5-(4-chlorophenyl)furan derivatives with inhibitory activity on tubulin polymerization.
    Moussa SA; A Osman EE; Eid NM; Abou-Seri SM; El Moghazy SM
    Future Med Chem; 2018 Aug; 10(16):1907-1924. PubMed ID: 29966433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a novel Coumarin-Dihydroquinoxalone derivative MY-673 as a tubulin polymerization inhibitor capable of inhibiting the ERK pathway with potent anti-gastric cancer activities.
    Song J; Wang SY; Wang X; Jia MQ; Tian XY; Fu XJ; Jin CY; Zhang SY
    Bioorg Chem; 2023 Aug; 137():106580. PubMed ID: 37149948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural-Product-Inspired Discovery of Trimethoxyphenyl-1,2,4-triazolosulfonamides as Potent Tubulin Polymerization Inhibitors.
    Rao VK; Ashtam A; Panda D; Guchhait SK
    ChemMedChem; 2024 Jan; 19(1):e202300562. PubMed ID: 37975190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.